In addition, only tumor cells treated with the combination are likely to have a sufficient number of cell-bound antibodies to induce efficient C3 opsonization, required to initiate complement-mediated-cytotoxicity and macrophage-mediated tumor cell killing [42]. This evidence concerns the gene C3 and neoplasm.